An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
Atlanta, Georgia, USA
Joined January 2009
- Tweets12.6K
- Following4.4K
- Followers31.5K
- Likes5.2K
Pinned Tweet
Just released! The Annual Report to the Nation on the Status of Cancer shows that from 2019-2023, overall cancer death rates decreased largely due to fewer deaths from lung cancer.
See trends in new cancer cases and deaths: acsjournals.onlinelibrary.wi…
#CancerAnnualReport @OncoAlert
ALT American Cancer Society and Cancer journal logo followed by the article title "Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer." Figure shows national trends in cancer death rates chart for males and females by average annual percent change (AAPC) from 2019 – 2023.
A recent @AmericanCancer consensus workshop recommends new trial measurements to fast-track initial evaluation of multi-cancer early detection tests.
Read the #OpenAccess report: acsjournals.onlinelibrary.wi…
@OncoAlert @ACSNews @billdahutmd #MCED #CancerDetection
There’s a lot happening in #BreastCancer treatment. Looking for a breakdown?
🎙️ On #CancerSpeak, Drs. @oreganruth & @KalinskyKevin discuss the latest advances shaping care, from treatment de-escalation to emerging therapies.
🔗: cancerspeak.podbean.com/e/to…
@OncoAlert #BCSM
ACS Journal Cancer retweeted
Ready to share your clinical trial results? Publish in @JournalCancer, an @AmericanCancer journal, and enjoy format-free submission, a supportive editorial team, and social promotion that gets your work seen.
Learn more: bit.ly/4xSJS6g
@PatelOncology
Publish your clinical trial results in @JournalCancer, an @AmericanCancer journal. Benefit from format-free submission, dedicated support staff, and broad social media promotion to maximize the visibility of your research.
Learn more: acsjournals.onlinelibrary.wi…
@PatelOncology
Tumor biology in #BreastCancer is important, but anatomic extent of disease still has a role in determining prognosis.
A recent study from @JenniferPlichta and @DukeSurgery investigators explains more: acsjournals.onlinelibrary.wi…
@OncoAlert @DukeCancer CC: @oreganruth #BCSM
Working in #pedonc, #ayacancer, or a related field? Follow @PedAYAJournal for updates on our new #OpenAccess journal.
Hear from @billdahutmd on how the journal aims to support research momentum across pediatric & AYA oncology.
See more: acsjournals.onlinelibrary.wi…
@OncoAlert
Which patients with metastatic APMS #ProstateCancer may benefit most from talazoparib + enzalutamide?
TALAPRO-3 findings highlight outcomes across HRR gene alterations. See our latest #CancerScope for more: acsjournals.onlinelibrary.wi…
@OncoAlert
A new @AmericanCancer study led by Erika Rees-Punia PhD reveals physical activity after a cancer diagnosis is linked to lower healthcare costs among older survivors.
Learn more: acsjournals.onlinelibrary.wi…
@OncoAlert @DrRobinYabroff @AlpaVPatel #ExerciseOncology #GeriOnc
As the use of CDK4/6 inhibitors in early-stage #BreastCancer grows, thoughtful patient selection matters.
A recent review explores how recurrence risk, side effects, treatment burden, and patient preferences can guide care.
🔗 acsjournals.onlinelibrary.wi…
@OncoAlert @adwilliams5
ACS Journal Cancer retweeted
Considering submitting your research to @PedAYAJournal? In this video, Dr. Nirali Shah discusses the types of manuscripts the journal is seeking.
Watch below or on YouTube: youtube.com/watch?v=MDuenIrM…
View our Author Guidelines: acsjournals.onlinelibrary.wi…
@OncoAlert #AYACSM #PedOnc
New in #CancerScope 📗 The RET inhibitor selpercatinib significantly improved EFS in comparison with a placebo for patients with early-stage RET-positive #NSCLC according to results of the LIBRETTO-432 trial.
See our coverage of the findings: acsjournals.onlinelibrary.wi…
@OncoAlert
#OpenAccess 🔓 Efficacy of a structured rehabilitation program for patients with terminal cancer: A multicenter randomized controlled trial
acsjournals.onlinelibrary.wi…
@OncoAlert
The VOICES of Black Women Study is addressing critical research gaps in cancer risk & outcomes.
@Dr_LEMcCullough examines its impact in CancerSpeak & an editorial in CANCER.
📖 Read: acsjournals.onlinelibrary.wi…
🎧 Listen: cancerspeak.podbean.com/e/th…
@OncoAlert
Results of two late-breaking trials presented at #ASCO26 show that ivonescimab combined with chemotherapy improved overall survival, and sunvozertinib improved progression-free survival, for patients with #NSCLC.
Read our latest #CancerScope: acsjournals.onlinelibrary.wi…
@OncoAlert
ACS Journal Cancer retweeted
⭐️The weight of the enemy: Tumor burden as a tumor‐agnostic prognostic marker and the limits of immunotherapy - Subbiah - 2026 - Cancer - Wiley Online Library @EladSharonMD @JournalCancer @ACSCAN @OncoAlert
acsjournals.onlinelibrary.wi…
New from @MoffittNews @GuardantHealth researchers 💡
In IDH1+ aCCA, immunotx added to GemCis was assoc w/ inferior rwOS. Findings support obtaining ctDNA-based CGP before initiating 1L therapy & underscore the need for prospective studies.
acsjournals.onlinelibrary.wi…
@OncoAlert
New editorial by Drs. Weam Almasaud & Ronda Lun of @DCNSNeuro 🧠 Increased risk of stroke after a new cancer diagnosis—Where are the knowledge gaps currently? acsjournals.onlinelibrary.wi…
Accompanying article: acsjournals.onlinelibrary.wi…
@OncoAlert #neuroonc
New & #OpenAccess 🔓 C-reactive protein kinetics may help assess early response and prognosis in biliary tract cancer treated with chemoimmunotherapy. However, these findings require prospective external validation in larger cohorts.
acsjournals.onlinelibrary.wi…
@OncoAlert
ACS Journal Cancer retweeted
Revisit the 2025 @AmericanCancer report providing statistics on lobular breast cancer in the United States published in @JournalCancer: bit.ly/4j6NH49
The article is also featured in Wiley's #BreastCancerAwarenessMonth collection: bit.ly/4j6HK7u
#BCAM #BCSM 🩷
ALT This Breast Cancer Awareness Month, revisit the 2025 American Cancer Society report providing statistics on lobular breast cancer in the United States.
New #OpenAccess review article summarizes the current evidence supporting the use of #ProtonTherapy across major disease sites and discusses ongoing studies likely to further define the role of proton therapy in modern oncology.
acsjournals.onlinelibrary.wi…
@OncoAlert #RadOnc
